Injectable fillers are increasingly used for midface augmentation, which can be performed for
facial rejuvenation and treatment of HIV facial lipoatrophy. A variety of temporary and …

Injectable fillers are widely used for facial rejuvenation, correction of disabling volumetric fat
loss in HIV-associated facial lipoatrophy, Romberg disease, and post-traumatic facial …

Background: Soft-tissue fillers have become more prevalent for facial augmentation in the
last 2 decades, even though complications of permanent fillers can be challenging to treat …

Background: Injectable fillers such as poly-L-lactic acid (PLLA) and calcium hydroxylapatite
(CaHA) have shown promising results in the treatment of combination antiretroviral therapy …

Objectives To ascertain by MRI the presence of filler injected into facial soft tissue and
characterize complications by contrast enhancement. Methods Nineteen volunteers without …

HIV facial lipoatrophy (FLA) is characterized by facial volume loss. HIV FLA affects the facial
contours of the cheeks, temples, and orbits, and is associated with social stigma. Although …

The objective of this study was to assess the safety and efficacy of injectable semipermanent
and permanent dermal fillers, compared to other facial augmentation techniques, for the …

OBJECTIVES This study sought to assess the radiographic appearance produced by
calcium hydroxylapatite soft tissue filler (CaHA; Radiesse, BioForm Medical Inc.) following …

Background Despite being considered a non-invasive procedure, injections can cause
adverse outcomes including infections, overfilling, asymmetry, foreign body granulomas …

Facial filler injections represent an ever-expanding market of nonsurgical facial
rejuvenation. Second only to botulinum toxin type A injections, soft tissue fillers comprised …